Navigation Links
New Test Developed to Identify LQTS syndrome

Researchers at the Mayo Clinic have discovered the epinephrine QT stress test that can predict the long QT syndrome with an accuracy of about 75%. //

The Long QT syndrome is a rare yet almost fatal, heart rhythm disorder occurring right from birth and affecting about one in every 3000 people in the United States. Its name comes from the elongated Qt interval seen in the electrocardiogram (ECG ) of such people with the disease.

If untreated, 50% of the people with symptoms of LQTS will die within 10 years of the first diagnosis of the disease.

However type 1 LQTS, a common subtype of the LQTS syndrome may go unrecognized because the patient’s resting ECG could be normal. In the epinephrine QT stress test, a patient is medicated to stimulate the heart in such a way that it mimics exercise revealing concealed type 1 long QT syndrome with an accuracy of about 75%.

This in turn can be confirmed by a blood test for LQTS genetic testing.

147 individuals, ages 8-59, who been referred to Mayo Clinic’s Long QT Syndrome Clinic during the period between 1999 and 2002 had an epinephrine QT stress test. A paradoxical lengthening of the QT interval was observed in 96%of these patients during infusion of the epinephrine.

These results could help physicians to recognize, evaluate and diagnose LQTS.

Although the treatment for LQTS patients can vary the options include medication or the implantation of a cardioverter defibrillator.


'"/>




Page: 1

Related medicine news :

1. Scientists Developed Map For Brain Molecular Communities
2. Scientists Developed Cheap Way To Assess Sleep
3. Diabetic Friendly Egg Developed In India
4. Three In One Ultrasound Probe For 3-D Imaging Of Heart And Tissue Destruction Developed
5. Cervical Cancer Vaccine To Be Developed In India
6. Anti-Microbial Coating For Use Over Biomedical Devices Developed
7. Cure for Osteoarthritis To Be Developed
8. Mice With Human Thought Processes Could Be Developed In The Future
9. Viagra Pill For Women To Be Developed
10. Male Contraceptive Pill Being Developed By Berlin Pharmaceutical
11. New Fertility Predictor Test Developed
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/21/2017)... ... February 21, 2017 , ... Doctors on Liens has ... by Dr. Kendell Mendonca , to its growing network of doctors in Central ... injuries stemming from car accidents such as whiplash, back pain, neck pain, hip and ...
(Date:2/21/2017)... Carrollton, Ga. (PRWEB) , ... February 21, 2017 , ... ... industry. To simplify the secure exchange of data across industry solutions, Fogo Data ... in the power of community. A healthy community is one in which all ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... the predictive analytic firm Predixion’s Healthcare IT practice. Predixion, which raised $42M+ to ... backed by giants including Accenture, GE Ventures, and Software AG , will ...
(Date:2/21/2017)... ... February 21, 2017 , ... CLICKco LLC, a company dedicated ... are now available for purchase on RonnieColemanNutrition.com, a popular website for health and ... health-conscious consumers who love coffee but are looking to add more protein to ...
(Date:2/20/2017)... ... , ... Nancy Johnston Toll marks her debut in the publishing ... Bump in the Road ” (published by Xlibris). Inspired from her personal experiences, this ... ups and downs experienced by anyone going through cancer treatment and how one can ...
Breaking Medicine News(10 mins):
(Date:2/21/2017)...  Luminex Corporation (NASDAQ: LMNX ) (the "Company") ... initiation of a quarterly cash dividend to its shareholders, the ... be payable on April 14, 2017 to shareholders of record ... The board of directors intends for the ... to holders of its common stock, representing a planned annual ...
(Date:2/21/2017)... , Feb. 21, 2017  /PR Newswire/ -- ... pleased to announce the launch of Modern Retina ... website for retina specialists. Built upon the ... focuses on the latest innovations in the areas ... and practice management. By meeting current informational needs and ...
(Date:2/21/2017)... 2017   BeyondSpring Pharmaceuticals , a clinical ... innovative immuno-oncology cancer therapies, today announced that the ... Phase 2 trial of BeyondSpring,s innovative lead asset, ... cell lung cancer (NSCLC) with Docetaxel has been ... Clinical Immuno-Oncology Symposium in Orlando, Fla. ...
Breaking Medicine Technology: